Scholars@Duke publication: In the pipeline: Galeterone lowers PSA in CRPC study: Commentary

construction release_alert

Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.

cancel

In the pipeline: Galeterone lowers PSA in CRPC study: Commentary

Publication , Other

Moul, JW

Published in: Oncology Report

May 1, 2012

Duke Scholars

Author Judd Wendell Moul Urology

Published In

Oncology Report

ISSN

1548-5323

Publication Date

May 1, 2012

Issue

MAY

Start / End Page

12

Related Subject Headings

Oncology & Carcinogenesis

Citation

APA

Chicago

ICMJE

MLA

NLM

Moul, J. W. (2012). In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report.

Moul, J. W. “In the pipeline: Galeterone lowers PSA in CRPC study: Commentary.” Oncology Report, May 1, 2012.

Moul JW. In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report. 2012. p. 12.

Moul, J. W. “In the pipeline: Galeterone lowers PSA in CRPC study: Commentary.” Oncology Report, no. MAY, 1 May 2012, p. 12.

Moul JW. In the pipeline: Galeterone lowers PSA in CRPC study: Commentary. Oncology Report. 2012. p. 12.

Published In

Oncology Report

ISSN

1548-5323

Publication Date

May 1, 2012

Issue

MAY

Start / End Page

12

Related Subject Headings

Oncology & Carcinogenesis